(2S,3R)-3-(3-Carboxy-4-bromophenyl)pyrrolidine-2-carboxylic Acid Hydrochloride

ID: ALA4068651

Chembl Id: CHEMBL4068651

PubChem CID: 137633113

Max Phase: Preclinical

Molecular Formula: C12H13BrClNO4

Molecular Weight: 314.13

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cl.O=C(O)c1cc([C@H]2CCN[C@@H]2C(=O)O)ccc1Br

Standard InChI:  InChI=1S/C12H12BrNO4.ClH/c13-9-2-1-6(5-8(9)11(15)16)7-3-4-14-10(7)12(17)18;/h1-2,5,7,10,14H,3-4H2,(H,15,16)(H,17,18);1H/t7-,10+;/m1./s1

Standard InChI Key:  NXAYZLNELKIUOC-QJVKKXMWSA-N

Associated Targets(non-human)

Grik1 Glutamate receptor ionotropic kainate 1 (319 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Grik2 Glutamate receptor ionotropic kainate 2 (298 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Grik3 Glutamate receptor ionotropic kainate 3 (207 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 314.13Molecular Weight (Monoisotopic): 312.9950AlogP: 1.68#Rotatable Bonds: 3
Polar Surface Area: 86.63Molecular Species: ZWITTERIONHBA: 3HBD: 3
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 0.51CX Basic pKa: 11.34CX LogP: -0.69CX LogD: -4.11
Aromatic Rings: 1Heavy Atoms: 18QED Weighted: 0.79Np Likeness Score: 0.39

References

1. Gynther M, Proietti Silvestri I, Hansen JC, Hansen KB, Malm T, Ishchenko Y, Larsen Y, Han L, Kayser S, Auriola S, Petsalo A, Nielsen B, Pickering DS, Bunch L..  (2017)  Augmentation of Anticancer Drug Efficacy in Murine Hepatocellular Carcinoma Cells by a Peripherally Acting Competitive N-Methyl-d-aspartate (NMDA) Receptor Antagonist.,  60  (23): [PMID:29205034] [10.1021/acs.jmedchem.7b01624]

Source